NBTX
Nanobiotix S.A.
NASDAQ · Healthcare · Biotechnology · FR
$38.80
−3.00%Margins
Gross margin
100.0%
EBITDA margin
-352.8%
EBIT margin
-352.8%
Net margin
-410.2%
FCF margin
-242.1%
109.0%
Return on equity
-135.9%
Return on assets
-731.0%
Return on invested capital
0.40x
Asset turnover
-$61.6M
Cash from operations
$1.21
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025